Valentina Giansante

Dr. Valentina Giansante

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VGValentina Giansante
Valentina Giansante
GSGianmarco Stati
Gianmarco Stati
SSSilvia Sancilio
Silvia Sancilio
Emanuela GuerraEmanuela Guerra
Emanuela Guerra
Saverio AlbertiSaverio Alberti
Saverio Alberti
Roberta Di PietroRoberta Di Pietro
Roberta Di Pietro
Pancreatic cancer (PC) is the seventh leading cause of cancer-related death. PC incidence has continued to increase by about 1% each year in both men and women. Although the 5-year relative survival rate of PC has increased from 3% to 12%, it is still the lowest among cancers. Hence, novel therapeutic strategies are urgently needed. Challenges in PC-targeted therapeutic strategies stem from the high PC heterogeneity and from the poorly understood interplay between cancer cells and the surrounding microenvironment. Signaling pathways that drive PC cell growth have been the subject of intense scrutiny and interest has been attracted by necroptosis, a distinct type of programmed cell death. In this review, we provide a historical background on necroptosis and a detailed analysis of the ongoing debate on the role of necroptosis in PC malignant progression.

14 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
VGValentina Giansante
Valentina Giansante
GSGianmarco Stati
Gianmarco Stati
SSSilvia Sancilio
Silvia Sancilio
Emanuela GuerraEmanuela Guerra
Emanuela Guerra
Saverio AlbertiSaverio Alberti
Saverio Alberti
Roberta Di PietroRoberta Di Pietro
Roberta Di Pietro
Pancreatic cancer (PC) is the seventh leading cause of cancer-related death. PC incidence has con-tinued to increase by about 1% each year in both men and women. Although the 5‐year relative survival rate of PC has increased from 3% to 12%, it is still the lowest among cancers. Hence, novel therapeutic strategies are urgently needed. Challenges in PC-targeted therapeutic strate-gies stem from the high PC heterogeneity and from the poorly understood interplay between cancer cells and the surrounding microenvironment. Signaling pathways that drive PC cell growth have been the subject of intense scrutiny and interest has been attracted by necroptosis, a distinct type of programmed cell death. In this review, we provide a historical background on necroptosis and a detailed analysis of the ongoing debate on the role of necroptosis in PC malignant progression.

Verified
Journal Article
Open access
PDF file
VGValentina Giansante
Valentina Giansante
LALuca Di Angelo
Luca Di Angelo
CCChiara Calabrese
Chiara Calabrese
PSPaolo De Sanctis
Paolo De Sanctis
PRPaolo Regi
Paolo Regi
Roberta Di PietroRoberta Di Pietro
Roberta Di Pietro
Pancreatic cancer, most frequently as ductal adenocarcinoma (PDAC), is the third leading cause of cancer death. Clear-cell primary adenocarcinoma of the pancreas (CCCP) is a rare, aggressive, still poorly characterized subtype of PDAC. We report here a case of a 65-year-old male presenting with pancreatic neoplasia. A histochemical examination of the tumor showed large cells with clear and abundant intracytoplasmic vacuoles. The clear-cell foamy appearance was not related to the hyperproduction of mucins. Ultrastructural characterization with transmission electron microscopy revealed the massive presence of mitochondria in the clear-cell cytoplasm. The mitochondria showed disordered cristae and various degrees of loss of structural integrity. Immunohistochemistry staining for NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2 (NDUFA4L2) proved specifically negative for the clear-cell tumor. Our ultrastructural and molecular data indicate that the clear-cell nature in CCCP is linked to the accumulation of disrupted mitochondria. We propose that this may impact on the origin and progression of this PDAC subtype.